Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MICHIGAN CRITICAL CARE CONSULTANTS, INC.
- Proposal award date
- 2020-04-23
- Contract end date
- 2021-03-31
- UEI
- NVSPCRHNAF11
- Solicitation number
- PA19-272
- Topic code
- NICHD
Research abstract
ABSTRACTExtracorporeal membrane oxygenation (ECMO) is becoming increasingly utilized to provide
cardiopulmonary support in patients due to its versatility, immediate benefit, and relatively low cost. However,
there continues to be significant morbidity and mortality related to hemostatic complications, especially in the
neonatal and pediatric population. A few pediatric oxygenators are used in ECMO; however, all of these
devices only have short term approval and are currently used off label in ECMO. In addition, a variety of
monitors are needed in an ECMO circuit, which can add to the complexity of the work flow, as well as
introducing access sites that can disrupt the blood flow path. Currently, there is no such oxygenator approved
for this indication in pediatrics.The goal of this project is to develop a pediatric ECMO oxygenator with integrated sensors that is
optimized for long term use in pediatric ECMO. The proposed MC3 Ped-ECMO Oxygenator (PedOxy) will be
designed specifically with a flow path that minimizes clotting by avoiding areas of high shear as well as
stagnant zone. In addition, a simplified monitoring system will be integrated into the disposable oxygenator that
will provide real-time diagnostics, minimize blood path disruptions and simplify workflows. Phase I will include
optimizing the blood flow path and integrated sensor module. The manufacturing processes for creating the
unique flow path will be advanced. Feasibility will be established by evaluating performance of the PedOxy
against specific criteria unique to usage in the pediatric application. Phase II funding, if granted, will be
sufficient to complete verification/validation testing, transfer to manufacture, and FDA and CE mark
submissions. We have assembled a synergistic team of experts, clinicians, marketers, manufacturers and
engineers who are uniquely qualified to carry out the proposed work.NARRATIVEThere are approximately 3,000 neonatal and pediatric ECMO cases performed each year in the US. There
are a few pediatric oxygenators used in ECMO, but only have short term (6 hour approval). The goal of this
project is to develop a pediatric ECMO oxygenator with integrated monitoring that is optimized for long term
use in pediatric ECMO.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
68 SBIR/STTR records share this UEI (1991–2023). Reported award amounts total $29,918,691. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards